This week, we will discuss whether less is more when it comes to discontinuing dialysis in patients with AKI and a chance to recover.
Holy Mackerel! This week we will discuss fish oil use in maintenance hemodialysis patients. Could this be the one thing that bends the curve on CV mortality, or is it just a red herring?
This week, we will discuss the phase 3 ORIGIN3 trial of atacicept, an APRIL/BAFF inhibitor for use in IgAN.
Day 3 of Kidney Week. Sibeprenlimab and Balcinrenone on NEJM and Lancet, plus a couple of other non-kidneywk studies.
In this edition of #Nephstats, we look at Number Needed to Treat (NNT), a controversial topic creates ripples and roars on social media amongst stat savvy physicians, epidemiologists and biostatisticians. This seems like such a simple and easy number to make sense of a trial’s importance - what could be controversial or wrong about it?
Beautiful visual abstract by Dhwanil Patel
The polls are still open. Be aware, we are not accepting mail-in ballots. You need to vote in-person to be counted (and by “in-person” we mean click this link)
Guidelines always make for a difficult visual abstract. Priti Meena does a great job nevertheless.
Superb visual abstract from Denisse Arellano!
Pablo Galindo put together the visual abstract for this week’s NephJC
The freely filtered gang got together to discuss this trial. Check it out.
